Kathryn Mahoney, PharmD

Principal Clinical Scientist
Invivyd, Inc.

Disclosure(s): Adagio Therapeutics: Employee, Stocks/Bonds

Kathryn Mahoney is a principal clinical scientist at Invivyd, Inc where she contributes to monoclonal antibody (mAb) clinical trials for infectious diseases. Kathryn holds a Doctorate of Pharmacy degree from Purdue University, completed a PGY1 acute care pharmacy residency, and has 5 years experience in clinical research of infectious diseases.

Poster(s):

• 1113 - Clinical and Virologic Outcomes with Early Adintrevimab (ADI) Monoclonal Antibody Therapy in Mild and Moderate COVID-19
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET